Appia Bio has emerged from stealth with $52m in series A financing to commercialise cancer treatments based on research at UCLA.

UChicago once again invested in Kin Insurance, participating in a $63.9m series C round that brought its overall funding to nearly $150m.

The photonic computing technology spinout of MIT has now pocketed $113m in funding altogether.

UW spinout TwinStrand has completed a $50m series B round led by Section 32, while Alexandria Venture Investments invested a third time.

American Electric Power, Chevron and Equinor all participated in a round that increased the Stanford company’s total funding to $228m.

Harvard University’s endowment has participated in a funding round for the robo-advisory platform.

Novo Seeds co-led a $61.7m round for the oncology therapy developer to help commercialise research originating at University of Copenhagen and Rigshospitalet.

Stanford University returned for the cryptocurrency exchange infrastructure developer's series B round.

Duke spinout Istari Oncology has collected $43.5m out of a targeted $70m for its latest round.

First reported late last year, Sense Biodetection has confirmed a $50m series B round backed by Cambridge Innovation Capital.